AI ROI calculator
Model workflow volume, labor cost, setup cost, recurring cost and uncertainty. Check the visible formula before using the result.
Paul Okhrem's AI research library brings together data, comparisons, tools, templates and guides. Use the statistics to check outside evidence. Use the tools to test your own assumptions. Each company example states its source limits. Provider comparisons disclose Paul's commercial interest. Each resource explains its method and the decision it can inform.
Use this library to assess AI value, project evidence, controls and stop decisions. The collection connects working tools with source-graded statistics and named company examples.
Journalists citing this research can use the press and speaking resources for bios and attribution. Follow the research updates Atom feed for material page updates.
These guides explain executive roles, provider selection and control ownership. They are working aids, not certificates or a substitute for legal advice.
The label describes provenance, not quality. A calculator can be reproducible without proving an outcome. A company example can be documented without being independently audited.
| Asset type | What it contains | What it does not prove |
|---|---|---|
| Original, reproducible tool | Visible formula, scoring rule, assumptions, or editable template | That the tool caused a client result |
| Curated, source-graded evidence | External statistics with publisher, date, population, denominator, and limits | That an industry average applies to one company |
| Documented company example | A named organization, use case, and direct source | Independent validation of every provider claim |
| Disclosed commercial comparison | Buyer scenarios, provider sources, selection criteria, and publisher conflict | An independent analyst ranking or universal winner |
Use these resources in an executive working session. Calculator inputs stay in the browser. Editable downloads require no email address.
Model workflow volume, labor cost, setup cost, recurring cost and uncertainty. Check the visible formula before using the result.
Score economics, process, data, technology, governance, leadership and adoption. Name an evidence owner for each score.
Review controls across Govern, Map, Measure, Manage and EU readiness. Record minimum evidence and an accountable owner.
Plan executive questions, required outputs and decision gates across four phases.
Assess five levels across six dimensions. Identify the evidence and steps needed to move up one level.
Compare value, readiness, risk and adoption. Use explicit stop rules before ranking the remaining options.
Assess six governance domains, record evidence for each level and define the next control improvement.
Adapt staff rules for tools, data and human review. Download the template in Word or Markdown.
Document harm scenarios, controls and remaining risk before approval.
Organize questions about roles, risk and evidence. Check the official timeline before relying on a date.
Plan management-system work before an independent assessment.
Define the mandate, responsibilities and KPIs before hiring.
Request evidence about data, models, controls, costs and ownership before an investment.
These datasets group evidence by the decision it can support. Check the source date, population, geography and denominator before citing a figure.
Compare denominators, outcomes, samples, methods and measurement periods. Forecasts remain separate from observed results.
Agent adoption, economics, governance and failure risk, with source notes, charts and citation limits.
Sourced data on the AI consulting market, enterprise demand and pricing context.
Evidence on governance adoption, board oversight, model risk and operating controls.
Chief AI Officer demand, role design and evidence limits for fractional leadership.
Banking, fintech and insurance evidence, with source and deployment limits.
A repeatable method for separating AI mentions, citations, referral traffic and qualified pipeline.
Industry pages provide an outside view. Use a company baseline, workflow map and control assessment before making an investment decision.
Clinical, administrative and adoption evidence with source boundaries.
Claims, underwriting, service, fraud, governance and workforce evidence.
Maintenance, quality, supply chain, scheduling, robotics and implementation evidence.
Diligence, portfolio operations, value, risk and adoption evidence.
Discovery, merchandising, service, conversion, forecasting and named company evidence.
A directory of documented company deployments, organized by industry.
Banks and finance firms with sourced deployment figures.
Research milestones, clinical evidence and the limits of each source.
Company-reported support changes and the evidence needed to judge them.
Model limits, inventory exposure and the decisions behind the iBuying exit.
Paul Okhrem publishes these first-party comparisons and offers one of the services. They are buyer guides, not independent research, analyst awards or objective rankings. Check the criteria and primary provider sources. Change the weights for your mandate and run your own procurement process.
Options for providers, payers and life sciences teams, with the method and publisher conflict visible.
Strategy firms, boutiques and independent advisers grouped by buyer need.
Providers grouped by delivery model, with a disclosed first-party method.
Independent advisers and fractional CAIOs for CEO-level decisions.
Compare leadership scope, named ownership, fees and conflicts.
A page is not useful merely because it contains many numbers. This library keeps the practical artifact, the external evidence, the commercial service, and the claim boundary separate.
| Test | What the resource should show | Failure to avoid |
|---|---|---|
| Source | Named publisher, direct link, publication date, and context | Citing a secondary list that removed the denominator |
| Method | Formula, scoring rule, weights, assumptions, and decision threshold | A proprietary score that cannot be reproduced |
| Ownership | A named business, finance, risk, data, or technology owner | Assigning “the AI team” to every decision |
| Evidence limit | What the number or tool can and cannot establish | Treating an industry survey as a forecast for one company |
| Refresh | Visible review date and corrections route | Evergreen language attached to stale regulatory facts |
The consulting evidence register separates company delivery evidence from Paul's personal consulting work. Check the facts, roles and disclosures before attributing a result or credential.
Material editorial updates in the last 30 days.

Paul Okhrem reads every brief personally. Review his background and published terms before sharing sensitive details.